KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Merck (MRK) Accumulated Depreciation & Amortization (2016 - 2025)

Merck has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $21.9 billion for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 14.4% to $21.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 billion through Dec 2025, up 14.4% year-over-year, with the annual reading at $21.9 billion for FY2025, 14.4% up from the prior year.
  • Accumulated Depreciation & Amortization was $21.9 billion for Q4 2025 at Merck, up from $19.2 billion in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $21.9 billion in Q4 2025 and troughed at $5.0 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $9.5 billion (2021), against an average of $10.1 billion.
  • Year-over-year, Accumulated Depreciation & Amortization decreased 8.19% in 2021 and then skyrocketed 365220.0% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $673.0 million in 2021, then crashed by 99.26% to $5.0 million in 2022, then skyrocketed by 365220.0% to $18.3 billion in 2023, then grew by 4.87% to $19.2 billion in 2024, then rose by 14.4% to $21.9 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Accumulated Depreciation & Amortization are $21.9 billion (Q4 2025), $19.2 billion (Q4 2024), and $18.3 billion (Q4 2023).